Impact of genetic background and ablation of insulin receptor substrate (IRS)-3 on IRS-2 knock-out mice

被引:22
|
作者
Terauchi, Y
Matsui, J
Suzuki, R
Kubota, N
Komeda, K
Aizawa, S
Eto, K
Kimura, S
Nagai, R
Tobe, K
Lienhard, GE
Kadowaki, T
机构
[1] Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo 1138655, Japan
[2] JST, CREST, Kawaguchi 3320012, Japan
[3] Tokyo Med Univ, Anim Res Ctr, Div Lab Anim Sci, Tokyo 1608402, Japan
[4] RIKEN, Ctr Dev Biol, Lab Vertebrate Body Plan, Kobe, Hyogo 6500047, Japan
[5] Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA
关键词
D O I
10.1074/jbc.M211045200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although we and others have generated IRS-2 knockout (IRS-2(-/-)) mice, significant differences were seen between the two lines of IRS-2(-/-) mice in the severity of diabetes and alterations of beta-cell mass. It has been reported that although IRS-1 and IRS-3 knock-out mice showed normal blood glucose levels, IRS-1/IRS-3 double knock-out mice exhibited marked hyperglycemia. Thus, IRS-1 and IRS-3 compensate each other's functions in maintaining glucose homeostasis. To assess the effect of genetic background and also ablation of IRS-3 on IRS2-1-, we generated IRS-2/IRS-3 double knock-out (IRS2-1-IRS-3-1-) mice by crossing IRS-3(-/-) mice (129/Sv and C57B1/6 background) with our IRS-2(-/-) mice (CBA and C57B1/6 background). Intercrosses of IRS-2(+/-)IRS-3(+/-)mice yielded nine genotypes, and all of them including IRS-2(-/-)IRS-3(-/-) mice were apparently healthy and showed normal growth. However, at 10-20 weeks of age, 20-30% mice carrying a null mutation for the IRS-2 gene, irrespective of the IRS-3 genotype, developed diabetes. When mice with diabetes were excluded from the analysis of glucose and insulin tolerance test, IRS-2(-/-)IRS3(-/-) showed a degree of glucose intolerance and insulin resistance similar to those of IRS-2(-/-) mice. Both IRS2-1- and IRS-2(-/-)IRS-3(-/-) mice had moderately reduced beta-cell mass despite having insulin resistance. Insulin-positive beta-cells were decreased to nearly zero in IRS2(-/-) mice with diabetes. Although Pdx1 and glucose transporter 2 expressions were essentially unaltered in islets from IRS-2(-/-) mice without diabetes, they were dramatically decreased in IRS-2(-/-) mice with diabetes. Taken together, these observations indicate that IRS-3 does not play a role compensating for the loss of IRS-2 in maintaining glucose homeostasis and that the severity of diabetes in IRS-2(-/-) mice depends upon genetic background, suggesting the existence of modifier gene(s) for diabetes in mice of the 129/Sv genetic strain.
引用
收藏
页码:14284 / 14290
页数:7
相关论文
共 50 条
  • [41] Rapid induction of insulin resistance in opioid μ-receptor knock-out mice
    Cheng, JT
    Liu, IM
    Hsu, CF
    NEUROSCIENCE LETTERS, 2003, 339 (02) : 139 - 142
  • [42] Interaction between insulin receptor and IRS proteins in IR/IRS-1+/- and IR/IRS-2+/- mice
    Kido, Y
    Kanno, H
    Withers, DJ
    Burks, DJ
    Accili, D
    DIABETES, 1999, 48 : A10 - A10
  • [43] Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice
    Lastres-Becker, Isabel
    Brodesser, Susanne
    Luetjohann, Dieter
    Azizov, Mekhman
    Buchmann, Jana
    Hintermann, Edith
    Sandhoff, Konrad
    Schuermann, Annette
    Nowock, Joachim
    Auburger, Georg
    HUMAN MOLECULAR GENETICS, 2008, 17 (10) : 1465 - 1481
  • [44] Genetic mapping of IRS-2 by detection of SNPs and haplotypes associated with insulin resistance.
    Grigorescu, F
    Laurier, C
    El Mkadem, SA
    Molinari, N
    Clark, AG
    Cros, G
    Bringer, J
    Jaffiol, C
    DIABETOLOGIA, 2001, 44 : A91 - A91
  • [45] Impaired survival of differentiating β cells but no insulin secretory defects result from ablation of IRS-2
    Bonner-Weir, S
    Withers, DJ
    Weir, GC
    Jonas, JC
    DIABETES, 1999, 48 : A3 - A3
  • [46] MORPHOLOGICAL CHARACTERIZATION OF TESTES FROM INSULIN RECEPTOR SUBSTRATE (IRS) 2-DEFICIENT MICE
    Griffeth, R. J.
    Burks, D. J.
    REPRODUCTION FERTILITY AND DEVELOPMENT, 2011, 23 (01) : 216 - 216
  • [47] Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC)
    Piper, Andrew J.
    Clark, Jennifer L.
    Mercado-Matos, Jose
    Matthew-Onabanjo, Asia N.
    Hsieh, Chung-Cheng
    Akalin, Ali
    Shaw, Leslie M.
    PLOS ONE, 2019, 14 (08):
  • [48] Decreased IGF Type 1 Receptor Signaling in Mammary Epithelium during Pregnancy Leads to Reduced Proliferation, Alveolar Differentiation, and Expression of Insulin Receptor Substrate (IRS)-1 and IRS-2
    Sun, Zhaoyu
    Shushanov, Sain
    LeRoith, Derek
    Wood, Teresa L.
    ENDOCRINOLOGY, 2011, 152 (08) : 3233 - 3245
  • [49] Identification of a 14-3-3 Binding Site on Insulin Receptor Substrate (IRS) 2
    Neukamm, Sabine S.
    Mackintosh, Carol
    Morrice, Nick A.
    Lehmann, Rainer
    Haering, Hans-Ulrich
    Schleicher, Erwin D.
    Weigert, Cora
    DIABETES, 2011, 60 : A427 - A427
  • [50] Glucose- and insulin-induced phosphorylation of the insulin receptor and its primary substrates IRS-1 and IRS-2 in rat pancreatic islets
    Velloso, LA
    Carneiro, EM
    Crepaldi, SC
    Boschero, AC
    Saad, MJA
    FEBS LETTERS, 1995, 377 (03) : 353 - 357